Skip to main content
Toggle navigation
Login
Search
Home
Scientific Program
Back
Favorite
Like
Tweet
Print
Henrik Søndergaard, n/a
Director, Head of Tolerance Research Therapy Area
Nykode Therapeutics, Norway
Poster(s):
Th112 - Tolerogenic APC-targeted VaccibodyTM Vaccines Treat Disease in Mouse Models of Experimental Autoimmune Encephalomyelitis and Non-Obese Diabetes
Thursday, June 20, 2024
7:30 AM – 7:45 PM
PT